Piperoxan-hydrochloride-Benodaine-hydrochloride-DataSheet-MedChemExpress_第1页
Piperoxan-hydrochloride-Benodaine-hydrochloride-DataSheet-MedChemExpress_第2页
Piperoxan-hydrochloride-Benodaine-hydrochloride-DataSheet-MedChemExpress_第3页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEPiperoxan hydrochlorideCat. No.: HY-100850CAS No.: 135-87-5Synonyms: Benodaine hydrochloride分式: CHClNO分量: 269.77作靶点: Adrenergic Receptor作通路: GPCR/G Protein; Neuronal Signaling储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 m

2、onths-20C 1 month溶解性数据体外实验 DMSO : 31 mg/mL (114.91 mM)* means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制备储备液1 mM 3.7069 mL 18.5343 mL 37.0686 mL5 mM 0.7414 mL 3.7069 mL 7.4137 mL10 mM 0.3707 mL 1.8534 mL 3.7069 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。BIOLOGICAL

3、ACTIVITY物活性 Piperoxan hydrochloride种 2 肾上腺素受体拮抗剂。IC50 & Target adrenoceptor 1体外研究When the medulla is superfused with 2 adrenoceptor antagonist Piperoxane (50 M; 5 min) while the pons1/2 Master of Small Molecules 您边的抑制剂师www.MedChemEis with artificial cerebrospinal fluid (ACSF), the three inactive pre

4、parations display rhythmic phrenic bursts ata low frequency (2-4 c/min), and the phrenic burst frequency of the 12 active ones significantly increasesduring the last 3 min of Piperoxane applications (16312% of the previous mean frequency). In activemedullary preparations, the effects of NA applicati

5、ons (25 M; 5 min) are compared when the preparationssre superfused either by ACSF (n=8) or by the 2 adrenoceptor antagonist Piperoxane (50 M; PIP-ACSF;n=5). NA applications either alone (NA-ACSF) or with Piperoxane (PIP-ACSF+NA) significantly increases thephrenic burst frequency. However, the blocka

6、ge of the medullary 2 adrenoceptors by Piperoxanepotentiates a phrenic burst frequency increase: during the fifth minute of NA applications, the phrenic burstfrequency reached 17111% of the mean control value when ACSF is applied alone and 23421% of themean control value when PIP-ACSF is applied in

7、control condition 1.PROTOCOLKinase Assay 1 The mouse neonates (P0-P3) are ether-anesthetized and decerebrated; the brain stems and the cervicalspinal cords are dissected out and placed ventral sides up in a 2 mL chamber superfused with artificialcerebrospinal fluid (ACSF) at 270.25C (meanSD), renewe

8、d at a rate of 2 mL/min. The ACSF containing(in mM) 129 NaCl, 3.35 KCl, 1.26 CaCl2, 1.15 MgCl2, 21 NaHCO3, 0.58 NaH2PO4, and 30 glucose isoxygenated and equilibrated (pH 7.4 at 27C) by bubbling carbogene (95% O2-5% CO2). In thepharmacological experiments, this is replaced by another ACSF in which bi

9、oreactive substances aredissolved: noradrenaline at 25 M (NA-ACSF) or 2 adrenoceptor antagonists, either Piperoxane at 50 M(PIP-ACSF) or yohimbine at 50 M (YO-ACSF). In some of the experiments, a patch-clamp microelectrode (1m diameter tip) is lowered within the ventral pons into the A5 nucleus wher

10、e a solution of either ACSF or NA(1 mM) is pressure-ejected. The ejected volume is estimated 20 nL for a pressure pulse lasting 2 s 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Mice 2Administration 2 Male Balb-C mice are used, weighing betwe

11、en 20 and 25 g. In mice pretreated with the -adrenoceptorantagonist Piperoxan, or with naloxone, both at a dose of 310-5 mol /kg s.c. given 15 min before the aceticacid, the antinociceptive action of (-)-isoprenaline is only slightly antagonized. Dose-ratios of 1.45 and 1.7,are produced by these two

12、 antagonists.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Viemari JC, et al. Nasal trigeminal inputs release the A5 inhibition received by the respiratory rhythm generator of the mouse neonate. JNeurophysiol. 2004 Feb;91(2):746-58.2. Bentley GA, et al. The antinociceptive action of some beta-adrenoceptor agonists in mice. Br J Pharmacol. 1986 Jul;88(3):515-21.McePdfHeightCaut

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论